https://www.selleckchem.com/pr....oducts/20-hydroxyecd
The present study indicates that AF-patients with a lower quality of life at diagnosis were most likely to improve their EHRA score after 12months. This effect was most prominent in patients ≥65years of age and patients 75years of age, compared to patients 65 and ≥75years, respectively. Future research should focus on further defining characteristics of these age groups to enable the implementation of age-tailored treatment. 65 and ≥75 years, respectively. Future research should focus on further defining characteristi
Like
Comment
Share
